Elizabeth A. Chrischilles

powered by
COS Expertise®
University of Iowa
College of Public Health
Marvin A. and Rose Lee Pomerantz Chair in Public HealthAppointed: 2007
University of Iowa
College of Public Health
Epidemiology
Associate Head for Admissions and CurriculumAppointed: 2000
University of Iowa
College of Public Health
Epidemiology
ProfessorAppointed: 2000
University of Iowa
College of Pharmacy
Clinical and Administrative Pharmacy
Professor (secondary)Appointed: 2000
Professional Headshot of Elizabeth A. Chrischilles

Mailing Address

C21-J General Hospital
University of Iowa
Iowa City, Iowa 52242
United States

Contact Information

Phone: (319) 384-5009
Fax: (319) 384-5004
e-chrischilles@uiowa.edu
http://www.public-health.uiowa.edu/faculty-staff/faculty/directory/faculty-detail.asp?emailAddress=e-chrischilles@uiowa.edu

Qualifications

Ph.D., University of Iowa, Pharmacy, 1986.
M.S., University of Iowa, Pharmacy, 1981.
B.S., University of Iowa, Pharmacy, 1979.

Expertise and Research Interests

My research interests include the following:
Healthcare effectiveness research;
Medication use and effects among the elderly;
Pharmacoepidemiology;
Pharmacoeconomics; and
Health services epidemiology.

I'm currently working on the following projects:
A statewide model of antimicrobial resistance and prescribing;
Linked databases for cancer health services research: prostate cancer project and breast cancer project;
Assessing clinical management of chemotherapy-related neutropeniain aggressive NHL and non-metastatic breast cancer;
Prevention of secondary conditions among people with mobility limitations;
Childhood asthma SCOR and community asthma plan intervention study;
Compliance with respiratory medications among adults: study in a large managed care organization;
Designing an alternative reimbursement system for Iowa pharmacists who provide case managed care; and
Medical management of benign prostatic hypertrophy: assessment of costs and outcomes using a large Medigap insurance database.

Other Expertise

I have contributed the following book chapters:
Chrischilles EA, Nduaguba M, Wallace RB, Semla TP. Psychotropic drug use and health outcomes in nursing homes. In: Pharmacoepidemiology. SA Edlavitch, Ed. Chelsea, MI: 1989.
Chrischilles EA. Cost-effectiveness analysis. In: Principles of Pharmacoeconomics: Implications for drug therapy decisions. JL Bootman, RJ Townsend, WF McGhan, Eds. Cincinnati, OH: Harvey Whitney Boos, 1991.
Chrischilles EA. What are the necessary and desirable attributes of the research infrastructure for studying patient outcomes of pharmaceutical care interventions?. In: Patient Outcomes of Pharmaceutical Interventions: A Scientific Foundation for the Future. American Pharmaceutical Association, 1994.
Chrischilles EA. Cost-effectiveness analysis. In: Principles of Pharmacoeconomics: Implications for drug therapy decisions, Second Edition. JL Bootman, RJ Townsend, WF McGhan, Eds. Cincinnati, OH: Harvey Whitney Books, 1996.
Chrischilles EA, Sorofman B. Integrating Pharmaceutical Care into Community Practice. In: Pharmaceutical Care and Community Practice: The Status of Pharmaceutical Care. 1996.

Keywords

COS Keywords:

Clinical Trial, Gerontology, Pharmaceuticals, Technology Assessment.

Additional Terms:

Adverse Effect, Aging, Clinical Trial, Comparative Effectiveness, Computer Modelling, Computer Simulation, Drug Effect, Drug Safety, Drug Therapy, Drug Therapy Intervention, Drug Use, Elderly, Geriatrics, Gerontology, Medication Management, Pharmaceutical, Pharmacoepidemiology, Technology Assessment.

Memberships

American College of Clinical Pharmacy
American Pharmacists Association
American Public Health Association
American Society of Clinical Oncology
American Society of Hospital Pharmacists (ASHP)
Drug Information Association
International Society for Pharmacoepidemiology
Iowa Pharmacists Association
Society for Epidemiologic Research

Honors and Awards

2007, Marvin A. and Rose Lee Pomerantz Chair in Public Health, College of Public Health, University of Iowa
2007, College of Public Health Distinguished Faculty Lecturer, College of Public Health, University of Iowa
2005, Wiederholdt Prize, American Pharmacists Association
2004, Faculty Teaching Award, College of Public Health, University of Iowa
2000, Collegiate Teaching Award, University of Iowa
1997, Appreciation Award, Iowa Pharmacists Association
1987-1992, Scholars Award in Pharmacoepidemiology, Burroughs Wellcome Fund

Previous Positions

1999-2000, Associate Professor, University of Iowa, College of Public Health, Epidemiology
1994-1999, Associate Professor, University of Iowa, Carver College of Medicine, Preventive Medicine
1987-1994, Assistant Professor, University of Iowa, Carver College of Medicine, Preventive Medicine
1986-1987, Visiting Assistant Professor, University of Iowa, Carver College of Medicine, Preventive Medicine
1982-1984, Clinical Pharmacy Faculty, Cedar Rapids Medical Education Program, Cedar Rapids, IA
1982-1984, Clinical Pharmacist & Pharmacist Manager, Pioneer Medical Center, Mechanicsville, IA
1982-1984, Clinical Assistant Professor, University of Iowa, College of Pharmacy, Clinical/Hospital Pharmacy
1981-1982, Clinical Pharmacy Fellow, University of Iowa, College of Pharmacy, Family Practice

Funding Received

  • Merck & Company, Inc.: Principal Investigator, Fracture Intervention Trial Health Economic Substudy Analysis Vertebral Arm, $39,558, Sep 5, 1997 to Sep 4, 1998.
  • National Institutes of Health (NIH): Co-Investigator, Exposure Intervention in a Rural Pediatric Asthma Cohort, Peter Thorne, PI, $1,946,270, Sep 30, 2001 to Jul 31, 2006.
  • Iowa Pharmacist's Association: Principal Investigator, Demonstration Project Study of On-Line Prospective Drug Utilization Review for OBRA '90, $1,990,206, Sep 30, 1992 to Sep 30, 1998.
  • SmithKline Beecham Pharmaceuticals: Principal Investigator, Cost-Effectiveness of Calcium Carbonate for Osteoporosis, $47,971, Oct 1, 1992 to Apr 30, 1993.
  • Amgen, Inc.: Principal Investigator, Assessing the Clinical Management of Chemotherapy-related Neutropenia for Patients Undergoing Treatment of Aggressive Non-Hodgkin's or Non-Metastatic Breast Cancer, $294,772, Nov 30, 1996 to Dec 31, 1998.
  • Norwich-Eaton Pharmaceutical Company: Principal Investigator, Study on Cost-Effectiveness of ICD, $72,260, Nov 28, 1988 to Nov 27, 1990.
  • Amgen, Inc.: Principal Investigator, Impact of Patient and Provider Characteristics on the Treatment, Outcomes and Costs of Neutropenia among Patients with NHL, $199,998, Nov 12, 2001 to Nov 11, 2002.
  • Iowa Department of Public Health / NIH: Co-Investigator, Asthma Surveillance in Iowa, Laurence Fuortes, PI, $40,000, Nov 1, 2000 to Sep 29, 2001.
  • National Institutes of Health (NIH): Co-Investigator, Asthma Center - Airway Disease in Children from Rural Communities, Gary Hunninghake, PI, $2,825,817, Nov 1, 1998 to Oct 31, 2003.
  • American College of Preventive Medicine: Principal Investigator, Pharmacoepidemiology Scholar Award Application, $250,000, May 22, 1987 to May 23, 1992.
  • Boehringer-Ingelheim Pharmaceuticals, Inc.: Co-Investigator, Development of a Cost-Effectiveness Model for Tamsulosin in the Treatment of Benign Prostatic Hyperplasia (BPH), Robert Ohsfeldt, PI, $72,849, May 17, 2002 to May 17, 2003.
  • National Institutes of Health (NIH): Co-Investigator, A GIS-Based Workbench to Interpret Cancer Maps, Gerard Rushton, PI, $1,329,115, May 1, 2002 to Apr 30, 2005.
  • National Institutes of Health (NIH): Co-Investigator, Master Agreement for Birth Defect Studies, James Hanson, PI, May 1, 1990 to Apr 30, 1995.
  • Iowa Medical Society / Wellmark Foundation: Principal Investigator, Statewide Model of Antibiotic Use and Resistance Prevention, $70,500, Mar 30, 2000 to Sep 30, 2002.
  • Iowa Pharmacy Foundation: Principal Investigator, Statewide Survey on Drug Use Surveillance Activities, $6,000, Mar 16, 1990 to Feb 28, 1991.
  • Iowa Department of Human Services / NIH: Principal Investigator, Pharmaceutical Case Management, $609,959, Jun 1, 2000 to Mar 31, 2003.
  • American Society of Consultant Pharmacists: Principal Investigator, Continuous Pharmaceutical Care: A Community-Based Demonstration Project, $30,000, Jun 1, 1995 to Jun 1, 1997.
  • Hoescht Marion Roussell, Inc.: Principal Investigator, Economic Analysis of Data from DZPR0183, $67,202, Jul 31, 1995 to Jan 31, 1997.
  • Procter and Gamble Company: Principal Investigator, Osteoporosis Forecasting Model, $25,313, Jul 29, 1994 to Dec 31, 1999.
  • Iowa Department of Public Health / NIH: Co-Investigator, Preventing Secondary Conditions in Persons with Disabilities, Don VanDyke and Scott Lindgren, PIs, $278,985, Jul 1, 2000 to Mar 31, 2007.
  • Iowa Department of Public Health / NIH: Principal Investigator, Disability Data Analysis, $285,502, Jul 1, 1997 to Jun 30, 2001.
  • Pharmacia & Upjohn Company: Principal Investigator, Costs and Health Effects of Parkinson's Disease Extension: Data Preparation and Delivery to Research Triangle Institute, $6,965, Jan 7, 1997 to Feb 7, 1997.
  • Amgen, Inc.: Principal Investigator, Impact of Patient and Provider Characteristics on the Treatment, Outcomes and Costs of Neutropenia among Patients with NHL: Analysis of the National SEER-Medicare Linked Database, $193,256, Jan 23, 2003 to Jan 22, 2004.
  • U.S. Department of Defense: Principal Investigator, Unbiased Outcome Estimates for Conservative vs. Aggressive Treatment of Early Stage Prostate Cancer from Retrospective Data: An Instrumental Variables Approach, $370,583, Jan 1, 1998 to Mar 31, 2002.
  • American Pharmaceutical Association: Principal Investigator, Short-Run Advancement of APHA Science Initiative, $8,750, Jan 1, 1994 to Jun 30, 1994.
  • Association of Occupational and Environmental Clinics / NIH: Co-Investigator, Midwestern Regional Pediatric Environmental Health Center, Joel Kline, PI, $252,000, Feb 1, 2001 to Jan 31, 2003.
  • Boehringer Ingelheim Pharmaceuticals, Inc.: Principal Investigator, Respiratory Medication Compliance in a Large Managed Care Organization, $344,720, Feb 1, 1999 to Aug 31, 2000.
  • Upjohn Company: Principal Investigator, Costs and Health Effects of Parkinson's Disease, $335,506, Dec 1, 1993 to Aug 30, 1996.
  • Marion Maerrell Dow: Principal Investigator, The Pharmacoepidemiology/Pharmacoeconomics Training Program at the University of Iowa, $100,000, Dec 1, 1992 to Jun 30, 1995.
  • Iowa Pharmacy Foundation: Principal Investigator, Pharmaceutical Care Provided in a Community Pharmacy, $40,000, Aug 1, 1992 to Dec 31, 1999.
  • U.S. Environmental Protection Agency: Co-Investigator, Children's Center--The Etiology and Pathogenesis of Airway Disease in Children from Rural Communities, Gary Hunninghake, PI, $3,393,270, Aug 1, 1988 to Jul 31, 2003.
  • National Institutes of Health (NIH): Co-Investigator, United States Renal Data Systems Special Studies Centers (USRDS-SSCs), Lawrence Hunsicker, PI, $751,063, Apr 10, 2000 to Apr 9, 2005.
  • Iowa Department of Public Health / NIH: Principal Investigator, State Capacity Building Project, $90,307, Apr 1, 2002 to Mar 31, 2003.
  • U.S. Department of Veterans Affairs: Principal Investigator, Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients, $31,800, Apr 1, 2001 to Sep 30, 2003.
  • Jen Associates, Inc. / Boehringer-Ingelheim Pharmaceuticals, Inc.: Principal Investigator, Alpha Blocker Medication Patterns Among Men with Benign Prostatic Hyperplasia (BPH), $97,499, Apr 1, 1999 to Mar 31, 2000.
  • University of Illinois: Principal Investigator, Cost-Effectiveness of Pharmacy Study, $6,000, Apr 1, 1995 to Jun 30, 1995.
  • AHRQ: Principal Investigator, Personal Health Records and Elder Medication Use Quality, $282,329 - ann direc, 2007 to 2010.
  • Merck Company Foundation: Principal Investigator, Merck Predoctoral Fellowship in Epidemiology, $40,000, 2006 to 2011.
  • CDC: Principal Investigator, Pharmaceutical Case Management and Living Welll with a Disability, $221,325, 2006 to 2009.
  • NIH: Principal Investigator, University of Iowa Older Adults CERT, $543,388-ann direct, 2006 to 2011.
  • UI/MC Lymphoma SPORE/National Cancer Institute: Principal Investigator, Heterogeneity of Treatment Benefit by Grade of Follicular Lymphoma, 2004 to 2004.
  • NIH: Co-Investigator, Health and Health Services Use in the HRS/AHEAD, $245,886, 2004 to 2009.
  • NIH: Co-Investigator, Collaborative Management of Hypertension, B Carter, PI, $417,527, 2003 to 2006.
  • NIH: Co-Investigator, Improving Adherence to Blood Pressure Guidelines, B Carter, PI, $457,810, 2003 to 2008.
  • NIH: Co-Investigator, Integrating Aging and Cancer Research, R Wallace, PI, $422,411, 2003 to 2008.
  • National Institutes of Health (NIH): Co-Investigator, Lung Cancer Care Outcomes/Surveillance Consortium - Iowa, Robert Wallace, PI, $404,311, 2001 to 2007.
  • Centers for Disease Control and Prevention: Principal Investigator, Care Access, Drug Effects, Aging and Mobility Disability, $237,643, 2000 to 2004.

Publications

  • Chrischilles EA, VanGilder R, Wright K, Kelly M, Wallace RB (Jun 2009) Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults., Journal of the American Geriatrics Society, 57 (6), 1000-6 Abstract
  • Wolinsky FD, Bentler SE, Liu L, Obrizan M, Cook EA, Wright KB, Geweke JF, Chrischilles EA, Pavlik CE, Ohsfeldt RL, Jones MP, Richardson KK, Rosenthal GE, Wallace RB (Feb 2009) Recent Hospitalization and the Risk of Hip Fracture Among Older Americans., The journals of gerontology. Series A, Biological sciences and medical sciences Abstract
  • Zhao Y, Brooks JM, Flanigan MJ, Chrischilles EA, Pendergast JF, Hunsicker LG (Dec 2008) Physician access and early nephrology care in elderly patients with end-stage renal disease., Kidney international, 74 (12), 1596-602 Abstract
  • Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, Hartz AJ (Apr 2008) A Cluster Randomized Trial to Evaluate Physician/Pharmacist Collaboration to Improve Blood Pressure Control., Journal of clinical hypertension (Greenwich, Conn.), 10 (4), 260-271 Abstract
  • Wolinsky FD, Liu L, Miller TR, An H, Geweke JF, Kaskie B, Wright KB, Chrischilles EA, Pavlik CE, Cook EA, Ohsfeldt RL, Richardson KK, Rosenthal GE, Wallace RB (Feb 2008) Emergency department utilization patterns among older adults., The journals of gerontology. Series A, Biological sciences and medical sciences, 63 (2), 204-9 Abstract
  • Park TR, Brooks JM, Chrischilles EA, Bergus G (2008) Estimating the effect of treatment rate changes when treatment benefits are heterogeneous: antibiotics and otitis media., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 11 (2), 304-14 Abstract
  • Brooks JM, Chrischilles EA (2007) Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methods, Med Care, 45 (10 Supl 2), S123-30
  • Wolinsky FD, Miller TR, Geweke JF, Chrischilles EA, An H, Wallace RB, Pavlik CE, Wright KB, Ohsfeldt RL, Rosenthal GE (2007) An interpersonal continuity of care measure for medicare part B claims analyses, J Gerontol B Psychol Sci Soc Sci, 62 (3), S160-8
  • Heederik D, Sigsgaard T, Thorne PS, Kline JN, Avery R, Bønløkke JH, Chrischilles EA, Dosman JA, Duchaine C, Kirkhorn SR, Kulhankova K, Merchant JA (Feb 2007) Health effects of airborne exposures from concentrated animal feeding operations., Environmental health perspectives, 115 (2), 298-302 Abstract
  • Wolinsky FD, Liu L, Miller TR, Geweke JF, Cook EA, Greene BR, Wright KB, Chrischilles EA, Pavlik C, An H, Ohsfeldt RL, Richardson KK, Rosenthal GE, Wallace RB (2007) The use of chiropractors by older adults in the United States, Chiropractic & Osteopathy (Epub ahead of print) http://www.chiroandosteo.com/content/15/1/12
  • Wolinsky FD, Miller TR, An H, Geweke JF, Wallace RB, Wright KB, Chrischilles EA, Liu L, Pavlik C, Cook EA, Ohsfeldt RL, Richardson KK, Rosenthal GE (2007) Hospital episodes and physician visits in the AHEAD cohort: the concordance between self-reports and Medicare claims, Medical Care, 45, 300-7
  • Chrischilles E, Rubenstein L, Van Gilder R, Voelker M, Wright K, Wallace R (2007) Risk factors for adverse drug events in older adults with mobility limitations in the community setting, J Am Geriatr Soc, 55 (1), 29-34
  • Brooks JM, Irwin CP, Hunsicker LG, Ianigan MJ, Chrischilles EA, Pendergast JF (2006) Effect of dialysis center profit-status on patient survival: A comparison of risk-adjustment and instrumental variable approaches, Health Services Research, 41 (6), 2267-89
  • Wilson RT, Chase GA, Chrischilles EA, Wallace RB (2006) Hip fracture risk among community-dwelling elderly people in the United States: A prospective study of physical, cognitive, and socioeconomic indicators, Am J Public Health, 96 (7), 1210-8
  • Chen-Hardee S, Chrischilles EA, Voelker MD, et al (2006) Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma, Cancer Causes and Control, 17 (5), 647-754
  • Carnahan RM, Lund BC, Perry PJ, Chrischilles EA (2006) Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy, Acta Psychiatrica Scandinavica, 113 (2), 135-41
  • Chrischilles EA, Klepser DG, Brooks JM, Voelker MD, Chen-Hardee SS, Scott SD, Link BK, Delgado DJ, Effect of Clinical Characteristics on Neutropenia-related Inpatient Costs Among Newly Diagnosed Non-Hodgkin's Lymphoma Cases During First-course Chemotherapy. [Article] Pharmacotherapy, 25(5), 668-75, May 2005
  • Melton LJ, Chrischilles EA, Cooper C, Lane AW, Riggs BL, How Many Women Have Osteoporosis?, Journal of Bone & Mineral Research, 20(5), 886-92, May 2005
  • Merchant JA, Naleway AL, Svendsen ER, Kelly KM, Burmeister LF, Stromquist AM, Taylor CD, Thorne PS, Reynolds SJ, Sanderson WT, Chrischilles EA (Mar 2005) Asthma and farm exposures in a cohort of rural Iowa children., Environmental health perspectives, 113 (3), 350-6 Abstract
  • Eggleston PA, Diette G, Lipsett M, Lewis T, Tager I, McConnell R, Chrischilles E, Lanphear B, Miller R, Krishnan J (2005) Lessons learned for the study of childhood asthma from the Centers for Children's Environment and Disease Prevention Research, Environmental Health Perspectives, 113 (10), 1430-6
  • Durairaj L, Torner JC, Chrischilles EA, Sarrazin MSV, Yankey J, Rosenthal GE (2005) Hospital volume-outcome relationships among medical admissions to ICUs, Chest, 128 (3), 1682-9
  • Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK (2005) Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK. Improved survival of follicular lymphoma patients in the United States, Journal of Clinical Oncology, 23 (22), 5019-26
  • Ayanian JZ, Chrischilles EA, Fletcher RH, Fouad MN, Harrington DP, Kahn KL, Kiefe CI, Lipscomb J, Malin JL, Potosky AL, Provenzale DT, Sandler RS, van Ryn M, Wallace RB, Weeks JC, West DW, Understanding Cancer Treatment and Outcomes: the Cancer Care Outcomes Research and Surveillance Consortium, Journal of Clinical Oncology, 22(24), 5026, 15 Dec 2004
  • Carnahan RM, Lund BC, Perry PJ, Chrischilles EA, The concurrent use of anticholinergics and cholinesterase inhibitors: Rare event or common practice?, Journal of the American Geriatrics Society, 52(12), 2082-7, Dec 2004
  • Ayanian JZ, Chrischilles EA, Wallace RB, Fletcher RH, Fouad MN, Kiefe CI, Harrington DP, Weeks JC, Kahn KL, Malin JL, Lipscomb J, Potosky AL, Provenzale DT, Sandler RS, van Ryn M, West DW, Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 22(15), 2992-6, August 2004 Abstract
  • Voelker MD, Chrischilles, Wright KB, Link BK, Park T, Delgado DJ (2004) Factors associated with first course chemotherapy among older patients with newly diagnosed non-Hodgkin's lymphoma: national SEER-Medicare study, Journal of Clinical Oncology (Supplement), 22 (14S), abstract 6118
  • Chrischilles E, Ahrens R, Kuehl A, Kelly K, Thorne P, Burmeister L, Merchant J., Asthma prevalence and morbidity among rural Iowa schoolchildren, Journal of Allergy and Clinical Immunology, 113(1), 66-71, January 2004
  • Davila JA, Brooks JM, Pendergast JF, Chrischilles EA, The effect of physician characteristics and their practice environment on surgical referral patterns for early-stage breast cancer in Iowa, American Journal of Medical Quality, 19(6), 266-73, 2004
  • Chrischilles EA, Carter BL, Lund BC, Rubenstein LM, Chen-Hardee SS, Voelker MD, Park TR, Kuehl AK (May-Jun 2004) Evaluation of the Iowa Medicaid Pharmaceutical Case Management Program, JAPHA, 44 (3), 337-49
  • Brooks JM, Chrischilles EA, Scott SD, Chen-Hardee SS, Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa, Health Services Research, 38(6 Part 1), 1385-1402, December 2003
  • Chrischilles EA, Rubenstein LM, Voelker MD, Wright KB, Link BK, Brooks JM, Delgado DJ (2003) Granulocyte Colony-Stimulating Factor Use During First Course Chemotherapy for Non-Hodgkin s Lymphoma: National SEER-Medicare Study, Annual Meeting, American Society of Hematology, Blood 102(11):1817 pages
  • Lund BC, Chrischilles EA, Carter BL, Ernst ME, Perry PJ, Development of a computer algorithm for defining an active drug list using an automated pharmacy database, Journal of Clinical Epidemiology, 56(8), 802-6, August 2003 Abstract
  • Nygaard I, Turvey C, Burns TL, Chrischilles E, Wallace R, Urinary incontinence and depression in middle-aged United States women, Obstetrics and Gynecology, 101(1), 149-56, 2003
  • Scott SD, Chrischilles EA, Link B, Delgado DJ, Fridman M, Stolshek BS, Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-hodgkin's lymphoma treated with chemotherapy, JMCP, 9, 15-21, 2003
  • Carter BL, Chrischilles EA, Scholz D, Hayase N, Bell N, Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program, Journal of the American Pharmaceutical Association (washington,d.c. : 1996), 43(1), 24-33, 2003 Abstract
  • Voelker MD, Rubenstein LM, Chrischilles EA, Chen-Hardee SS, Link BK, Wright KB, Brooks JM, Delgado DJ (2003) Time to First Neutropenia Hospitalization During First Course Chemotherapy Among Newly Diagnosed Non-Hodgkin s Lymphoma Patients: National SEER-Medicare Study, Blood, 102 (11), 253A 888
  • Brooks JM, Voelker MD, Chen-Hardee SS, Park T, Wright K, Link BK, Chrischilles EA, Rubenstein LM, Delgado DJ (2003) Neutropenia-Related Inpatient Medicare Costs During First Course Chemotherapy Among Newly Diagnosed Non-Hodgkin s Lymphoma Patients, Blood, 102 (11), 498A 1812 Part1
  • Chrischilles E, Gilden D, Kubisiak J, Rubenstein L, Shah H., Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers, American Journal of Managed Care, 8(10), 902-11, October 2002 Abstract
  • Chrischilles EA, Fulda TR, Byrns PJ, Winckler SC, Rupp MT, Chui MA, The role of pharmacy computer systems in preventing medication errors, Journal of the American Pharmaceutical Association (washington,d.c. : 1996), 42(3), 439-48, 2002 Abstract
  • Chrischilles E, Delgado D.J, Stolshek B.S, Lawless G, Fridman M, Carter WB, Impact of age and colony-stimulating factor use on hospital length of stay for febrile neutropenia in CHOP-treated non-Hodgkin's lymphoma, Cancer Control : Journal of the Moffitt Cancer Center, 9(3), 203-11, 2002 Abstract
  • Voelker MD, Saag KG, Schwartz DA, Chrischilles E, Clarke WR, Woolson RF, Doebbeling BN, Health-related quality of life in Gulf War era military personnel, American Journal of Epidemiology, 155(10), 899-907, May 2002 Abstract
  • Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL, Linking clinical variables to health-related quality of life in Parkinson's disease, Parkinsonism & Related Disorders, 8(3), 199-209, January 2002 Abstract
  • Wakefield BJ, Blegen MA, Uden-Holman T, Vaughn T, Chrischilles E, Wakefield DS, Organizational culture, continuous quality improvement, and medication administration error reporting, American Journal of Medical Quality : the Official Journal of the American College of Medical Quality, 16(4), 128-34, 2001 Abstract
  • Chrischilles E, Rubenstein L, Chao J, Kreder K.J, Gilden D, Shah H., Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study, Clinical Therapeutics, 23(5), 727-43, May 2001 Abstract
  • Merlino LA, Bagchi I, Taylor TN, Utrie P, Chrischilles E, Sumner W 2nd, Mudano A, Saag KG, Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients, Medical Decision Making : an International Journal of the Society for Medical Decision Making, 21(2), 122-32, 2001 Abstract
  • Rubenstein LM, DeLeo A, Chrischilles EA, Economic and health-related quality of life considerations of new therapies in Parkinson's disease, Pharmacoeconomics, 19(7), 729-52, 2001 Abstract
  • Chrischilles EA, Dasbach EJ, Rubenstein LM, Cook JR, Tabor HK, Black DM, Fracture Intervention Trial Research Group, The effect of alendronate on fracture-related healthcare utilization and costs: the fracture intervention trial, Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa, 12(8), 654-60, 2001 Abstract
  • Brooks JM, Chrischilles E, Scott S, Ritho J, Chen-Hardee S, Information gained from linking SEER Cancer Registry Data to state-level hospital discharge abstracts. Surveillance, Epidemiology, and End Results, Medical Care, 38(11), 1131-40, November 2000 Abstract
  • Armstrong EP, Chrischilles EA, Electronic prescribing and monitoring are needed to improve drug use, Archives of Internal Medicine, 160(18), 2713-4, October 2000 Abstract
  • Chrischilles EA, Scholz DA, Dollars and sense: a practical guide to cost analysis for hospital epidemiology and infection control, Clinical Performance and Quality Health Care, 7(2), 107-11, 1999 Abstract
  • Hoerger TJ, Bala MV, Rowland C, Greer M, Chrischilles EA, Holloway RG, Cost effectiveness of pramipexole in Parkinson's disease in the US, Pharmacoeconomics, 14(5), 541-57, November 1998 Abstract
  • Kuehl AK, Chrischilles EA, Sorofman BA, System for exchanging information among pharmacists in different practice environments, American Journal of Health-system Pharmacy : Ajhp : Official Journal of the American Society of Health-system Pharmacists, 55(10), 1017-24, May 1998 Abstract
  • Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL, The health burdens of Parkinson's disease, Movement Disorders : Official Journal of the Movement Disorder Society, 13(3), 406-13, May 1998 Abstract
  • Rubenstein LM, Voelker MD, Chrischilles EA, Glenn DC, Wallace RB, Rodnitzky RL, The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's disease research, Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 7(4), 279-90, May 1998 Abstract
  • Phillips CR, Bjornson DC, Chrischilles E, Sorofman B, Larson L, The pharmacist's assessment of second generation on-line prospective drug utilization review, Journal of Managed Care Pharmacy, 4, 183-191, 1998
  • Chrischilles EA, Gondek K, Do practice guidelines augment drug utilisation review?, Pharmacoeconomics, 12(6), 648-66, December 1997 Abstract
  • Carter BL, Barnette DJ, Chrischilles E, Mazzotti GJ, Asali ZJ, Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting, Pharmacotherapy, 17(6), 1274-85, 1997 Abstract
  • Rubenstein LM, Chrischilles EA, Voelker MD, The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey, Pharmacoeconomics, 12(4), 486-98, October 1997 Abstract
  • Taylor TN, Chrischilles EA, Economic evaluation of interventions in endocrinology, Endocrinology and Metabolism Clinics of North America, 26(1), 67-87, March 1997 Abstract
  • Schwartz DA, Doebbeling BN, Merchant JA, et al (The Iowa Persian Gulf Study Group), Self-reported illness and health status among Gulf War veterans, JAMA, 277(3), 238-245, 1997
  • Saag KG, Rubenstein LM, Chrischilles EA, Wallace RB, Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly., Journal of Rheumatology, 22(11), 2142-7, November 1995 Abstract
  • Glynn RJ, Brock DB, Harris T, Havlik RJ, Chrischilles EA, Ostfeld AM, Taylor JO, Hennekens CH, Use of antihypertensive drugs and trends in blood pressure in the elderly, Archives of Internal Medicine, 155(17), 1855-60, September 1995 Abstract
  • Lipton HL, Byrns PJ, Soumerai SB, Chrischilles EA, Pharmacists as agents of change for rational drug therapy, International Journal of Technology Assessment in Health Care, 11(3), 485-508, Summer 1995 Abstract
  • Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P, Drug data coding and analysis in epidemiologic studies, European Journal of Epidemiology, 10(4), 405-11, August 1994 Abstract
  • Pahor M, Guralnik JM, Salive ME, Chrischilles EA, Manto A, Wallace RB, Disability and severe gastrointestinal hemorrhage. A prospective study of community-dwelling older persons, Journal of the American Geriatrics Society, 42(8), 816-25, August 1994 Abstract
  • Pahor M, Guralnik JM, Chrischilles EA, Wallace RB, Use of laxative medication in older persons and associations with low serum albumin, Journal of the American Geriatrics Society, 42(1), 50-6, January 1994 Abstract
  • Layfield LJ, Chrischilles EA, Cohen MB, Bottles K, The palpable breast nodule. A cost-effectiveness analysis of alternate diagnostic approaches, Cancer, 72(5), 1642-51, September 1993 Abstract
  • Chrischilles EA, Wallace RB, Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population, Journal of Gerontology, 48(3), M91-6, May 1993 Abstract
  • Chrischilles EA, Segar ET, Wallace RB, Self-reported adverse drug reactions and related resource use. A study of community-dwelling persons 65 years of age and older, Annals of Internal Medicine, 117(8), 634-40, October 1992 Abstract
  • Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL, Perspective. How many women have osteoporosis?, Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research., 7(9), 1005-10, September 1992 Abstract
  • Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, Glynn RJ, Ostfeld AM, Guralnik JM, Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly, Journal of Gerontology, 47(5), M137-44, September 1992 Abstract
  • Xakellis GC, Chrischilles EA, Hydrocolloid versus saline-gauze dressings in treating pressure ulcers: a cost-effectiveness analysis, Archives of Physical Medicine and Rehabilitation, 73(5), 463-9, May 1992 Abstract
  • Chrischilles EA, Butler CD, Davis CS, Wallace RB, A model of lifetime osteoporosis impact, Archives of Internal Medicine, 151(10), 2026-32, October 1991 Abstract
  • Semla TP, Lemke JH, Helling DK, Wallace RB, Chrischilles EA, Perceived purpose of prescription drugs: the Iowa 65+ Rural Health Study, Dicp : the Annals of Pharmacotherapy, 25(4), 410-3, April 1991 Abstract
  • Baker KA, Levy SM, Chrischilles EA, Medications with dental significance: usage in a nursing home population, Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry., 11(1), 19-25, 1991 Abstract
  • Chrischilles EA, Lemke JH, Wallace RB, Drube GA, Prevalence and characteristics of multiple analgesic drug use in an elderly study group, Journal of the American Geriatrics Society, 38(9), 979-84, September 1990 Abstract
  • Chrischilles EA, Helling DK, Aschoff CR, Effect of clinical pharmacy services on the quality of family practice physician prescribing and medication costs, Dicp : the Annals of Pharmacotherapy, 23(5), 417-21, May 1989 Abstract
  • Chrischilles EA, Helling DK, Booth BM, Lemke JH, Mustion AL, Documentation and appropriateness of prescribing for Veterans Administration ambulatory-care patients, American Journal of Hospital Pharmacy, 45(11), 2345-51, November 1988 Abstract
  • Semla TP, Chrischilles EA, Helling DK, Lemke JH, Wallace RB, Drube GA, The relationship of nonsteroidal anti-inflammatory drug use to tinnitus in an elderly population, Drug Intelligence and Clinical Pharmacy, 20, 472, 1986
  • Chrischilles EA, Helling DK, Rowland CR, Cost-benefit analysis of clinical pharmacy services in three Iowa family practice offices, Journal of Clin Hosp Pharm, 10(1), 59-66, March 1985 Abstract
  • Chrischilles EA, Helling DK, Rowland CR, Clinical pharmacy services in family practice: cost-benefit analysis. II. Referrals, appointment compliance, and costs, Drug Intelligence and Clinical Pharmacy, 18(5), 436-41, May 1984 Abstract
  • Chrischilles EA, Helling DK, Rowland CR, Clinical pharmacy services in family practice: cost-benefit analysis. I. Physician time and quality of care, Drug Intelligence and Clinical Pharmacy, 18(4), 333-41, April 1984 Abstract
  • Chrischilles EA, Helling DK, Rowland CR, Model for cost-benefit analysis of clinical pharmacy in family practice, American Journal of Hospital Pharmacy, 39(6), 992-8, June 1982 Abstract

Profile Details

Last Updated: 9/10/2009

COS Expertise ID #215301
Reference this profile directly: http://myprofile.cos.com/chrische01